Antiviral Potency of Chitosan, Its Derivatives, and Nanocomposites
Authors:
- 2 October 2022
- book chapter
- Published by Springer Nature
- p. 273-289
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Antiviral activity of silver nanoparticle/chitosan composites against H1N1 influenza A virusDiscover Nano, 2013
- Novel polymeric inhibitors of HCoV-NL63Antiviral Research, 2013
- Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challengeArchives of Virology, 2012
- Dendritic Cell Targeted Chitosan Nanoparticles for Nasal DNA Immunization against SARS CoV Nucleocapsid ProteinMolecular Pharmaceutics, 2012
- Carbohydrate-Functionalized Chitosan Fiber for Influenza Virus CaptureBiomacromolecules, 2011
- Preparation and anti‐TMV activity of guanidinylated chitosan hydrochlorideJournal of Applied Polymer Science, 2009
- Chitin regulation of immune responses: an old molecule with new rolesCurrent Opinion in Immunology, 2008
- Chitosan as an adjuvant for parenterally administered inactivated influenza vaccinesArchives of Virology, 2008
- Chitin Micro-Particles (CMP): A Useful Adjuvant for Inducing Viral Specific Immunity when Delivered Intranasally with an HIV-DNA VaccineViral Immunology, 2003
- N-Carboxymethylchitosan-N,O-sulfate as an anti-HIV-1 agentBiochemical and Biophysical Research Communications, 1991